When do people with abdominal symptoms need a fast track referral?BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o1198 (Published 23 May 2022) Cite this as: BMJ 2022;377:o1198
- Helen Saul, editor in chief1,
- Deniz Gursul, research dissemination manager1,
- Georgios Lyratzopoulos, professor of cancer epidemiology2
- 1NIHR Centre for Engagement and Dissemination, Twickenham, UK
- 2Epidemiology of Cancer Healthcare and Outcomes (ECHO), University College London, UK
- Correspondence to H Saul
Herbert A, Rafiq M, Pham TM, et al. Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: a cohort study. PLoS Med 2021:18;e1003708.
To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/combining-risks-cancer-and-ibd-allows-more-fast-track-referrals/
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
All authors contributed to the development and review of this summary, as part of the wider NIHR Alerts editorial team.
More summaries of NIHR research are available at https://evidence.nihr.ac.uk/alerts/
Contributor: Holly Cave.
Disclaimer: NIHR Alerts are owned by the Department of Health and Social Care and are made available to The BMJ under licence. NIHR Alerts report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Alerts.
Permission to reuse these articles should be directed to NIHRAlerts@nihr.ac.uk